中文 | English
Return
Total: 38 , 1/4
Show Home Prev Next End page: GO
MeSH:(Acinetobacter Infections/drug therapy)

1.Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections

Uh Jin KIM ; Hee Kyung KIM ; Joon Hwan AN ; Soo Kyung CHO ; Kyung Hwa PARK ; Hee Chang JANG

Chonnam Medical Journal 2014;50(2):37-44

3.Influence of poly-β-1-6-N-acetylglucosamine on biofilm formation and drug resistance of Acinetobacter baumannii.

Haina GUO ; Jun XIANG

Chinese Journal of Burns 2015;31(1):45-47

4.Clinical characteristics and antibiotic resistance in children with invasive Acinetobacter baumannii infection.

Lin LIU ; Lin DONG ; Yue-Bo XU ; Zhao-Xing CHEN ; Jie-Min FAN

Chinese Journal of Contemporary Pediatrics 2013;15(5):379-382

6.The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii.

Na Young KWON ; Jae Deok KIM ; Hyun Joo PAI

The Korean Journal of Internal Medicine 2002;17(2):94-99

7.Clinical characteristics and therapy of pan-drug resistant Acinetobacter baumannii infection.

Shu-mei SUN ; Yin-yin WANG ; Cui-jun YAO ; Hai-lan LI ; Fang YU ; Ya-li ZHANG ; Hao ZHOU ; Neng-ping WANG

Journal of Southern Medical University 2010;30(10):2351-2359

8.Mechanisms of carbapenems resistance in acinetobacter and progress of treatment.

Wei ZHANG ; Kai-Zhong LIU

Journal of Zhejiang University. Medical sciences 2010;39(5):542-547

9.Study on the carbapenemase genotype and molecular epidemiology of Acinetobacter baumannii.

Li-pei QIU ; Deng PAN ; Wei-feng XU ; Hua ZHOU ; Ze-qing WEI ; Yun-song YU

Chinese Journal of Epidemiology 2007;28(4):381-384

10.Drug resistance and status of infection of Acinetobacter baumannii in burn intensive care unit during 3 years.

Bin CHEN ; Xiaojian LI ; Zhi ZHANG ; Xuhui ZHANG ; Zhongyuan DENG ; Xiaomin ZHONG ; Wenbin TANG ; Changling LIU ; Wenjuan CAO

Chinese Journal of Burns 2015;31(1):21-24

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 38 , 1/4 Show Home Prev Next End page: GO